Top compounds associated with response to IRF7


Feature Type Standardized
Nominal ANOVA
mRNA CEP-701 GDSC1000 pan-cancer AAC -0.081 0.02
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.075 0.02
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.065 0.02
mRNA BRD-A86708339 CTRPv2 pan-cancer AAC 0.11 0.02
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.26 0.02
mRNA paclitaxel gCSI pan-cancer AAC -0.12 0.02
mRNA brivanib CTRPv2 pan-cancer AAC -0.08 0.02
mRNA nelarabine CTRPv2 pan-cancer AAC -0.085 0.03
mRNA AZD4547 CTRPv2 pan-cancer AAC -0.083 0.03
mRNA regorafenib CTRPv2 pan-cancer AAC -0.081 0.03
Download CSV